This genetic testing service identifies mutations in BRCA1 and BRCA2 genes, linked to hereditary breast and ovarian cancers. Positive results inform tailored strategies: enhanced surveillance (e.g., mammograms, MRIs), risk-reduction options (prophylactic surgery), and family counselling. Designed for accessibility and proactive cancer prevention through evidence-based, patient-cantered hereditary cancer care.